Compounds, substrates and methods related to histone deacetylases
The invention relates to methods for the identification of compounds, peptides and proteins that can act as substrates for histone deacetylases. The invention further relates to compounds of Formula I: F 1 -X 1 -L 1 -X 2 -P 1 -X 3 -G 1 (Formula I) The invention relates to the treatment of diseases or disorders mediated by ARID1A (BAF250A).
1. A compound of Formula II:
or a pharmaceutically acceptable salt or ester thereof;
wherein R 1 is selected from halogen, C 1 -C 6 alkyl, substituted C 1 -C 6 alkyl, C 1 -C 6 alkenyl, substituted C 1 -C 6 alkenyl, C 1 -C 6 alkynyl and substituted C 1 -C 6 alkynyl; and,
R 2 is selected from —O—C 1 -C 6 alkyl, substituted —O—C 1 -C 6 alkyl, —SC 1 -C 6 alkyl and substituted —SC 1 -C 6 alkyl.
2. The compound of claim 1 having the formula:
or a pharmaceutically acceptable salt or ester thereof;
wherein R 1 is selected from the group consisting of F, Cl, I, methyl, ethyl, propyl, isopropyl, n-butyl, t-butyl and CF 3 ; and
R 2 is OCH 3 or —OCH 2 CH 3 .
3. The compound of claim 1 having the formula:
or a pharmaceutically acceptable salt thereof.